0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > Kits > PCSK9 > CEA-C202

ClinMax™ Human PCSK9 ELISA Kit

For research use only.

Order Now

    Product Details
    ClinMax™ Human PCSK9 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human PCSK9 that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:
    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.
  • Application

    The kit is developed for quantitative detection of natural and recombinant human PCSK9 in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow
     PCSK9 Workflow
    Key Features
    AnalytePCSK9
    Assay TypeSandwich-ELISA
    ReactivityHuman
    Sensitivity0.45 ng/ml
    Range0.625 ng/mL-20 ng/mL
    Assay Time2.75 hr
    Sample TypeCell Culture Supernatants, Plasma, Serum.
    Sample volume50 uL
    Format96-wells plate breakable into 12 x 8 wells strips

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Storage
    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Typical Data Please refer to DS document for the assay protocol.
 PCSK9 TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of PCSK9 is less than 0.45 ng/mL.

Validation
Sample Values

Serum – PCSK9 concentrations were measured in 24 human serum samples (dilution ratio 1:40), sample data shows in the figure below.

 PCSK9 SAMPLE VALUES
Dilution Linearity

High concentrations of human PCSK9 serum samples were diluted with 1:2, 1:4, 1:8 and 1:16 ratios for gradient dilution to evaluate the linearity of the assay. In the serum samples, the average detection rate of PCSK9 was 100.6%.

 PCSK9 DILUTION LINEARITY
Intra-Assay Statistics

Ten replicates of each of 3 samples containing different PCSK9 concentrations were tested in one assay. Acceptable criteria: CV<10%.

 PCSK9 INTRA-ASSAY STATISTICS
Inter-Assay Statistics

3 samples containing different concentrations of PCSK9 were tested in independent assays. Acceptable criteria: CV<15%.

 PCSK9 INTER-ASSAY STATISTICS
Recovery

Recombinant PCSK9 was spiked into 3 human serum samples, and then analyzed. The average recovery of PCSK9 for serum samples is 96.4%.

 PCSK9 RECOVERY
Materials Provided
IDComponentsSize
CEA202-C01Pre-coated Anti-PCSK9 Antibody Microplate1 plate
CEA202-C02Human PCSK9 Standard20 μg×2
CEA202-C03Biotin-Anti-PCSK9 Antibody Con. Solution100 μL
CEA202-C04Biotin-Antibody Dilution Buffer8 mL
CEA202-C05Streptavidin-HRP Con. Solution500 μL
CEA202-C06Streptavidin-HRP Dilution Buffer15 mL
CEA202-C0720× Washing Buffer50 mL
CEA202-C08Sample Dilution Buffer15 mL×2
CEA202-C09Substrate Solution12 mL
CEA202-C10Stop Solution6 mL
  • Clinical and Translational Updates

Comments (0)


ETA de productos en stock: 2 días laborables

Price(EUR) : €500.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:4 Details
  • Number of Drugs in Clinical Trials:27 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje